Purpose of Review Olfactory dysfunction is a frequent complication of SARS-CoV-2 infection.
This review presents the current literature regarding the management of post-COVID-19 …

… Loss of olfactory function is well recognised as a symptom of COVID‐19 infection, and the
… number of individuals with abnormalities in their sense of smell. For many, the condition is …

… With this review we aimed to comprehensively assess the benefits and harms of interventions
to treat post‐COVID‐19 related olfactory dysfunction, to ensure that patients can make an …

… Herein, we aimed to explore the integrity of the olfactory network in a cohort of patients
with COVID-19-related persistent OD through brain morphometry and graph-based network …

… in post-COVID-19 PPVOD. This study reports an olfactory recovery in post-COVID-19 …
That olfactory recovery was significant as the SST MCID increased by more than 6 points [17…

… viral olfactory dysfunction (PVOD) has long been recognized as a major cause of clinically
significant olfactory loss, … focusing on viral URI-induced olfactory loss and thus were excluded. …

… Position Paper on Olfactory Dysfunction [14], olfactory training is … olfactory training [39,40,41,42],
daily practicing with four odourants has become standard recommendation of COVID-19 …

… A recent randomized controlled trial (RCT) failed to prove the superiority of mometasone
furoate topical nasal therapy over OT in the treatment of post COVID-19 anosmia. [35]. Notably, …

… In the absence of demonstrable inflammatory disease observed with endoscopy or imaging,
it is unlikely that initiation of corticosteroid treatment would benefit post–COVID-19 OD, as is …

… olfactory receptor cells, but its effectiveness in patients with post-COVID-19 olfactory dysfunction
… OT versus placebo in the treatment of post-COVID-19 olfactory dysfunction. Twenty-five …